BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Bevacizumab
1
Investigating radiotherapy’s impact on intestinal perforation risk in gastrointestinal tumor patients treated with bevacizumab
12/11/2025 8:20:56 AM | Browse: 184 | Download: 691
2
Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis
8/25/2025 12:36:25 PM | Browse: 429 | Download: 1090
3
Two treatment methods for hepatocellular carcinoma: Lenvatinib or bevacizumab combined with sintilimab and interventional therapy
2/26/2025 4:21:32 AM | Browse: 369 | Download: 829
4
Atezolizumab and bevacizumab combination in advanced hepatocellular carcinoma patients: The imperative for safety assessment studies
12/12/2024 7:29:58 AM | Browse: 215 | Download: 766
5
Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatment
10/25/2024 10:27:31 AM | Browse: 356 | Download: 816
6
Clinical evaluation of sintilimab in conjunction with bevacizumab for advanced colorectal cancer with microsatellite stable-type after failure of first-line therapy
9/28/2024 4:34:28 AM | Browse: 362 | Download: 1390
7
Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1
8/8/2024 4:58:16 AM | Browse: 424 | Download: 1241
8
Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report
7/2/2024 8:41:38 AM | Browse: 390 | Download: 1181
9
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status
3/27/2024 1:28:19 PM | Browse: 250 | Download: 808
10
Chemotherapy combined with bevacizumab for small cell lung cancer with brain metastases: A case report
1/11/2024 5:28:10 AM | Browse: 482 | Download: 1860
11
Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen (CA) 125, CA199 analysis
1/2/2024 9:08:46 AM | Browse: 481 | Download: 1994
12
Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
10/25/2023 8:49:11 AM | Browse: 615 | Download: 1746
13
Massive bleeding from a gastric artery pseudoaneurysm in hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A case report
6/15/2023 12:09:46 PM | Browse: 528 | Download: 1620
14
Treatment outcome analysis of bevacizumab combined with cyclophosphamide and oxaliplatin in advanced pseudomyxoma peritonei
6/15/2023 12:09:45 PM | Browse: 323 | Download: 1557
15
Retrospective efficacy analysis of olaparib combined with bevacizumab in the treatment of advanced colorectal cancer
5/26/2023 9:50:16 AM | Browse: 619 | Download: 1844
16
Systemic treatment for unresectable hepatocellular carcinoma
3/10/2023 7:29:15 AM | Browse: 580 | Download: 1572
17
Synaptophysin-like 2 expression correlates with lymph node metastasis and poor prognosis in colorectal cancer patients
11/15/2022 10:19:35 AM | Browse: 822 | Download: 2594
18
Safety of endoscopy in patients undergoing treatments with antiangiogenic agents: A 5-year retrospective review
7/14/2022 8:05:03 AM | Browse: 1039 | Download: 2515
19
Arteriovenous thrombotic events in a patient with advanced lung cancer following bevacizumab plus chemotherapy: A case report
6/24/2022 9:00:24 AM | Browse: 917 | Download: 2212
20
Atezolizumab and bevacizumab as first line therapy in advanced hepatocellular carcinoma: Practical considerations in routine clinical practice
9/22/2021 8:09:41 AM | Browse: 939 | Download: 1411
21
Colorectal cancer metastatic to the breast: A case report
9/10/2020 5:57:28 AM | Browse: 1186 | Download: 2225
22
Mechanisms and anatomical risk factors of pneumothorax after Bevacizumab use: A case report
7/20/2020 2:28:50 AM | Browse: 1042 | Download: 2769
23
Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports
4/28/2020 8:04:31 AM | Browse: 1341 | Download: 2256
24
Primary tumor location and survival in colorectal cancer: A retrospective cohort study
4/15/2020 12:00:00 PM | Browse: 1274 | Download: 2539
25
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
2/22/2019 4:33:37 AM | Browse: 1352 | Download: 1745
26
Tertiary stent-in-stent for obstructing colorectal cancer: A case report and literature review
1/16/2019 8:39:45 AM | Browse: 1344 | Download: 2529
27
Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors
12/14/2018 10:51:23 AM | Browse: 1167 | Download: 1856
28
CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer
11/13/2018 8:04:45 AM | Browse: 1544 | Download: 2494
29
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
12/20/2016 1:38:00 PM | Browse: 1816 | Download: 2730
30
Role of targeted therapy in metastatic colorectal cancer
9/12/2016 10:43:00 AM | Browse: 1501 | Download: 2542
31
Treatment of diabetic retinopathy: Recent advances and unresolved challenges
8/23/2016 8:55:00 AM | Browse: 1676 | Download: 2518
32
Total and not bevacizumab-bound vascular endothelial growth factor as potential predictive factors to bevacizumab-based chemotherapy in colorectal cancer
7/15/2016 3:38:00 PM | Browse: 1766 | Download: 2752
33
Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment
9/30/2015 4:28:00 PM | Browse: 1702 | Download: 2421
34
Bevacizumab plus XELOX as first-line treatment of metastatic colorectal cancer: The OBELIX study
6/20/2015 5:38:00 PM | Browse: 1969 | Download: 3854
35
Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab
5/13/2015 10:38:00 AM | Browse: 1793 | Download: 3272
36
Value of bevacizumab in treatment of colorectal cancer: A meta-analysis
4/27/2015 4:29:00 PM | Browse: 1695 | Download: 2417
37
Targeted therapy in first line treatment of RAS wild type colorectal cancer
3/16/2015 6:04:00 PM | Browse: 1490 | Download: 2115
38
FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
2/11/2015 4:38:00 PM | Browse: 1658 | Download: 1782
39
Combinations of vascular endothelial growth factor pathway inhibitors with metronomic chemotherapy: Rational and current status
11/19/2014 2:49:00 PM | Browse: 1494 | Download: 1989
40
Bevacizumab maintenance in metastatic colorectal cancer: How long?
11/10/2014 12:19:00 PM | Browse: 1397 | Download: 2124
41
Preoperative intravitreal bevacizumab and silicone oil tamponade for vitrectomy in diabetic retinopathy
10/20/2014 9:54:00 AM | Browse: 1487 | Download: 2376
42
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases
9/16/2014 6:10:00 PM | Browse: 1559 | Download: 1613
43
Role of bevacizumab in colorectal cancer growth and its adverse effects: A review
9/15/2014 8:54:00 PM | Browse: 1557 | Download: 1758
44
Anti-angiogenic therapies for metastatic colorectal cancer: Current and future perspectives
9/11/2014 8:40:00 PM | Browse: 1433 | Download: 2078
45
Meta-regression of treatments for metastatic colorectal cancer: Quantifying incremental benefit from 2000 to 2012
9/3/2014 11:44:00 AM | Browse: 1551 | Download: 2159
46
Bevacizumab for the management of diabetic macular edema
9/1/2014 3:42:00 PM | Browse: 1522 | Download: 1642
47
Ranibizumab in diabetic macular edema
9/1/2014 2:50:00 PM | Browse: 1473 | Download: 1781
48
Molecular targeting therapy using bevacizumab for peritoneal metastasis from gastric cancer
9/1/2014 10:30:00 AM | Browse: 1609 | Download: 1440
49
Targeting receptor tyrosine kinases in gastric cancer
8/28/2014 5:50:00 PM | Browse: 1520 | Download: 1841
50
Bevacizumab in the pre-operative treatment of locally advanced rectal cancer: A systematic review
8/26/2014 5:16:00 PM | Browse: 1577 | Download: 1547